Sex, Lies, and Pharmaceuticals: How Drug Companies Plan to Profit from Female Sexual Dysfunction

Overview

Against a backdrop of virtual intercourse, online porn, and burgeoning Viagra sales, Sex, Lies, and Pharmaceuticals reveals how women?s sexual difficulties are being repackaged as symptoms of a new disorder. In this compelling book, award-winning journalist Ray Moynihan teams up with drug assessment specialist Barbara Mintzes to investigate the creation of female sexual dysfunction or FSD, and the marketing machine that promises to "cure" it. The authors go inside the corridors of medical power to visit drug ...

See more details below
Paperback
$16.19
BN.com price
(Save 9%)$17.95 List Price

Pick Up In Store

Reserve and pick up in 60 minutes at your local store

Other sellers (Paperback)
  • All (22) from $1.99   
  • New (10) from $3.47   
  • Used (12) from $1.99   
Sex, Lies, and Pharmaceuticals: How Drug Companies Plan to Profit from Female Sexual Dysfunction

Available on NOOK devices and apps  
  • NOOK Devices
  • Samsung Galaxy Tab 4 NOOK
  • NOOK HD/HD+ Tablet
  • NOOK
  • NOOK Color
  • NOOK Tablet
  • Tablet/Phone
  • NOOK for Windows 8 Tablet
  • NOOK for iOS
  • NOOK for Android
  • NOOK Kids for iPad
  • PC/Mac
  • NOOK for Windows 8
  • NOOK for PC
  • NOOK for Mac
  • NOOK for Web

Want a NOOK? Explore Now

NOOK Book (eBook)
$10.49
BN.com price
(Save 29%)$14.95 List Price

Overview

Against a backdrop of virtual intercourse, online porn, and burgeoning Viagra sales, Sex, Lies, and Pharmaceuticals reveals how women’s sexual difficulties are being repackaged as symptoms of a new disorder. In this compelling book, award-winning journalist Ray Moynihan teams up with drug assessment specialist Barbara Mintzes to investigate the creation of female sexual dysfunction or FSD, and the marketing machine that promises to "cure" it. The authors go inside the corridors of medical power to visit drug company–sponsored scientific meetings and medical education events where doctors are being trained to see women’s sexual problems as the symptoms of FSD — a pharmaceutically treatable condition. Moynihan and Mintzes explore the underlying causes of sexual dissatisfaction among women and expose how global drug companies exploit those problems in an attempt to create the next billion dollar disease.

Read More Show Less

Editorial Reviews

From the Publisher
"…a solid, detailed study of how the influence of the pharmaceutical industry may be distorting medical science"&#8212Library Journal
Library Journal
Moynihan (Selling Sickness), an academic researcher and health journalist in Australia, here monitors the creation of a new medical condition called female sexual dysfunction (FSD). It appears pharmaceutical companies are sponsoring relevant medical research, while helping to design the tools to diagnose FSD. Meanwhile, a feminist backlash is building against making a condition out of low desire. Moynihan reviews the pervasive support that pharmaceutical companies offer to medical associations, conferences, seminars, journals, and research studies. Mintzes (pharmacology, Univ. of British Columbia) contributes a chapter describing how Viagra and similar medications have been promoted. The public now sees erectile dysfunction as a physical problem that can easily be treated. Mintzes is concerned that something similar could happen with new drugs or hormones designed for women. VERDICT Moynihan presents a solid, detailed study of how the influence of the pharmaceutical industry may be distorting medical science. This book will be of most interest to students and those broadly concerned about health issues.—David R. Conn, Surrey P.L., B.C.
Read More Show Less

Product Details

  • ISBN-13: 9781553655084
  • Publisher: Greystone Books
  • Publication date: 10/1/2010
  • Pages: 272
  • Product dimensions: 5.50 (w) x 8.40 (h) x 0.70 (d)

Meet the Author

Ray Moynihan has been covering the business of health care for more than a decade with the Australian Broadcasting Corporation, the Australian Financial Review, and the British Medical Journal. He is an award-winning journalist and the author of three previous books, including Selling Sickness, which has been translated into a dozen languages.

Dr. Barbara Mintzes investigates the link between clinical trial and pharmacosurveillance evidence on drug safety and effectiveness, and provincial drug financing decisions. She holds a BA in geography from Simon Fraser University and a PhD in health care and epidemiology from UBC. She currently works at UBC in Vancouver as Assistant Professor in the Department of Pharmacology & Therapeutics.

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)